Category Archives: Stem Cell Therapy

Neuralstem Updates ALS Stem Cell Trial Progress

ROCKVILLE, Md., May 8, 2012 /PRNewswire/ –Neuralstem, Inc. (CUR) announced that the Federal Drug Administration (FDA) has approved the return of three patients from earlier cohorts in its ongoing Phase I safety trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) with its spinal cord stem cells (HSSC’s). These patients will be permitted to return to the trial for second treatments as the next cohort of patients, provided they meet inclusion requirements at the scheduled time Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , , , | Comments Off

TiGenix : presenting at Key Conferences – Spring 2012

Regulated information May 8, 2012 TiGenix to Present at Key Conferences Spring 2012 Leuven (BELGIUM) – May 8, 2012 – TiGenix (TIG.BR), a leader in the field of cell therapy, announced today that during the months of May and June the company will present at a number of key events in Europe and the U.S. geared at investor, industry, and academic audiences to highlight the commercial potential of ChondroCelect, the only approved cell therapy in Europe, and of the company`s innovative proprietary allogeneic stem cell platform with programs in Phase I, II, and III for a range of inflammatory and autoimmune diseases. May 15-16 BioEquity, Marriott Hotel, Frankfurt, Germany Presenter: Eduardo Bravo, CEO Date & time: Tuesday, May 15, 16:00-16:25 Room: Level 1, Room Gold 1 May 21-23 World Stem Cells and Regenerative Medicine Congress, Victoria Park Plaza, London, UK Presenter: Eduardo Bravo, CEO Date & time: Monday, May 21, 15:25 -15:50 Title: Cell Therapy & Regenerative Medicine – Progressing into phase III with an orphan indication May 24 Knowledge for Growth, ICC Ghent, Belgium Presenter: Eduardo Bravo, CEO Time: 11:30 Keynote speech – Advanced therapies: this time it is for real June 5-8 18th International Stem Cell Therapy Sociey Annual Meeting, Sheraton Seattle, WA, U.S. Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , | Comments Off

2 Cell Transplantation studies impact dental stem cell research for therapeutic purposes

Public release date: 8-May-2012 [ | E-mail | Share ] Contact: David Eve celltransplantation@gmail.com Cell Transplantation Center of Excellence for Aging and Brain Repair Tampa, Fla. (May. 8, 2012) Two studies appearing in a recent issue of Cell Transplantation (20:11-12), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, evaluate stem cells derived from dental tissues for characteristics that may make them therapeutically useful and appropriate for transplantation purposes Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , , , | Comments Off

Kudos to CIRM: Stem Cell Agency Sticks with Full Financial Disclosure

A key panel of directors of the $3 billion California stem cell agency yesterday voted unanimously to retain full public disclosure of the financial interests of its directors and top executives. The director’s Governance Subcommittee bypassed a proposal that would … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off

Researcher Alert: First Look at Proposed Rules for California’s Stem Cell Bank

The California stem cell agency today unveiled initial details of how it plans to run its $30 million bank of reprogrammed adult stem cells. The proposed regulations are the first step this year in the $3 billion agency’s project to … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off

ACT and CIRM Together on Eye Research Webinar

Executives of Advanced Cell Technology, which has been repeatedly rejected for funding by the $3 billion California stem cell agency, will participate this week in the agency’s Internet “webinar” on research involving the human eye. ACT, which is engaged in … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off

Stem cell therapy to battle HIV?

(SACRAMENTO, Calif.) — UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS. In a paper published in the May issue of the Journal of Virology, the UC Davis HIV team demonstrated both the safety and efficacy of transplanting anti-HIV stem cells into mice that represent models of infected patients. The technique, which involves replacing the immune system with stem cells engineered with a triple combination of HIV-resistant genes, proved capable of replicating a normally functioning human immune system by protecting and expanding HIV-resistant immune cells. Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , , , , | Comments Off

Novel stem cell transplantation holds promise for HIV prevention

UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS. In a paper published in the May issue of the Journal of Virology, the UC Davis HIV team demonstrated both the safety and efficacy of transplanting anti-HIV stem cells into mice that represent models of infected patients Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , | Comments Off

Bio-Matrix Subsidiary "First in Class" Approach to Stem Cell Medicine

SAN DIEGO, CA–(Marketwire -05/03/12)- Regen BioPharma (Regen), Inc. a newly-formed subsidiary of Bio-Matrix Scientific Group, Inc. (BMSN.PK – News) (BMSN.PK – News), unveiled today its operational plan for its “Super-Incubator” stem cell company. Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , , | Comments Off

Cryo-Cell International Taps Leader in Stem Cell Therapy to Serve as Chief Scientific Officer

OLDSMAR, Fla., May 3, 2012 (GLOBE NEWSWIRE) — via PRWEB – Cryo-Cell International, Inc. announced the appointment of Linda Kelley, Ph.D., as chief scientific officer. Dr Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , , , , | Comments Off

Researchers see hope in stem cell HIV treatment

U.S. Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , | Comments Off

A Media Event on Clinical Developments in Gene and Cell Therapy

Milwaukee, WI (PRWEB) May 02, 2012 Academic and industry leaders in gene and cell therapy will be featured at a Media Event in Philadelphia, PA on May 15, 2012, immediately preceding the 15th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) on May 16-19, 2012. The event will focus on recent clinical developments in targeted biotherapeutics for various diseases. Members of the media will also receive complimentary full-access registration to the ASGCT 15th Annual Meeting at the Pennsylvania Convention Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , , | Comments Off

Stem cell therapy shows promise in fight against HIV

ScienceDaily (May 2, 2012) UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS. In a paper published in the May issue of the Journal of Virology, the UC Davis HIV team demonstrated both the safety and efficacy of transplanting anti-HIV stem cells into mice that represent models of infected patients. The technique, which involves replacing the immune system with stem cells engineered with a triple combination of HIV-resistant genes, proved capable of replicating a normally functioning human immune system by protecting and expanding HIV-resistant immune cells. Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , | Comments Off

Improved adult-derived human stem cells have fewer genetic changes than expected

Public release date: 30-Apr-2012 [ | E-mail | Share ] Contact: Vanessa McMains vmcmain1@jhmi.edu 410-502-9410 Johns Hopkins Medical Institutions A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cellsso-called induced pluripotent stem (iPS) cellsand found that relatively few genetic changes occur during stem cell conversion by an improved method. The findings, reported in the March issue of Cell Stem Cell, the official journal of the International Society for Stem Cell Research (ISSCR), will be presented at the annual ISSCR meeting in June. Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , | Comments Off

Stem Cell Treatment Helps Pets with Arthritis and Hip Dysplasia

Sanford, FL (PRWEB) May 01, 2012 Veterinarians at Val-U-Vet are performing adipose stem cell therapy on dogs and cats suffering from arthritis, hip dysplasia and more. After treatment, severely arthritic pets experience substantial decrease in pain, and have significantly increased mobility. These are not the controversial embryonic stem cells of the past Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , | Comments Off

Stem cell therapy for WCMS student has remarkable results

When Tyler was born, the umbilical cord was wrapped around his neck, causing a lack of oxygen to his brain that led to Tyler suffering a stroke during delivery. The stroke caused damage to the back of Tylers brain Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , , , , | Comments Off

Study using stem cell therapy shows promise in fight against HIV

Public release date: 1-May-2012 [ | E-mail | Share ] Contact: Charles Casey charles.casey@ucdmc.ucdavis.edu 916-734-9048 University of California – Davis Health System UC Davis Health System researchers are a step closer to launching human clinical trials involving the use of an innovative stem cell therapy to fight the virus that causes AIDS. In a paper published in the May issue of the Journal of Virology, the UC Davis HIV team demonstrated both the safety and efficacy of transplanting anti-HIV stem cells into mice that represent models of infected patients Continue reading

Posted in Stem Cell Therapy | Tagged , , , , , , , , | Comments Off

Scientists discover tumor-targeting neural stem cells

Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off

Scientists discover neural stem cells with tumour targeting ability

SINGAPORE: Scientists at Singapore's Institute of Bioengineering and Nanotechnology (IBN) have discovered that neural stem cells possess the innate ability to target tumour cells outside the central nervous system.Source:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=IPS+stem+cells+therapy&eo=UTF-8

Posted in Stem Cell Therapy, Stem Cells | Comments Off

IBN DISCOVERS HUMAN NEURAL STEM CELLS, PROMISING DISCOVERY FOR BREAST CANCER THERAPY

SINGAPORE, April 20 (Bernama) — Could engineered human stem cells hold the keyto cancer survival?Scientists at the Institute of Bioengineering and Nanotechnology (IBN), theworld''s first bioengineering and nanotechnology research institute, havediscovered that neural stem cells possess the innate ability to … Continue reading

Posted in Stem Cell Therapy, Stem Cells | Comments Off